跳至主要内容
临床试验/NCT03244514
NCT03244514已完成不适用

Biomarker-guided Implementation of the Cardiovascular (CV) Surgery AKI Bundle to Reduce the Occurrence of AKI After Cardiac Surgery- Prevention of AKI

University Hospital Muenster24 个研究点 分布在 5 个国家目标入组 280 人开始时间: 2017年11月2日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
280
试验地点
24
主要终点
Compliance rate

研究概览

简要总结

There is no specific therapy for acute kidney injury. It is presumed that supportive measures improve the care and outcome of patients with acute kidney injury.

The investigators hypothesize that the implementation of a bundle of supportive measures adapted to patients undergoing cardiovascular surgery reduces the occurence of AKI.

A Randomized prospective multicenter trial is needed to investigate whether the implementation of the bundle of measures is effective to prevent AKI in high risk patients undergoing cardiac surgery. In this feasibility trial the investigators will analyze the compliance rate to the trial protocol in a multicenter, multinational cohort in preparation for a large randomized controlled trial.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult patients undergoing cardiac surgery with cardiopulmonary bypass (CPB)
  • Urinary [TIMP-2] * [IGFBP7] >= 0.3 4h after CPB
  • Written informed consent

排除标准

  • Preexisting AKI (stage 1 and higher)
  • Patients with cardiac assist devices (ECMO, LVAD, RVAD, IABP)
  • Pregnancy, breastfeeding
  • Known (Glomerulo-)-Nephritis, intersstitial nephritis or vasculitis
  • CKD with eGFR < 20 mL/min
  • Dialyses dependent CKD
  • Prior kidney transplant within the last 12 months

结局指标

主要结局

Compliance rate

时间窗: 48 hours after start of intervention

proportion of patients who are treated according to the trial protocol: CV surgery AKI bundle fulfilled at all time

次要结局

  • Free-days through of vasoactive medications and mechanical ventilation(28 days after start of intervention)
  • Renal recovery(90 days after start of intervention)
  • Moderate and severe AKI(72 hours after start of intervention)
  • Occurence of AKI(72 hours after start of intervention)
  • ICU and hospital stay(up to 1 year after start of intervention (until discharge))
  • Mortality(90 days after start of intervention)
  • Number of patients with renal replacement therapy(90 days after start of intervention)

研究者

发起方
University Hospital Muenster
申办方类型
Other
责任方
Sponsor

研究点 (24)

Loading locations...

相似试验

Biomarker-guided Implementation of the AKI Bundle | 临床试验